Article info
PDFEditorial commentary
CSF ferritin predicts CSF Aβ decline in biomarker-determined Alzheimer’s disease
- Correspondence to Dr James R Connor, Department of Neurosurgery, Penn State Hershey Medical Center, Hershey, PA 17033, USA; jconnor{at}pennstatehealth.psu.edu
Citation
CSF ferritin predicts CSF Aβ decline in biomarker-determined Alzheimer’s disease
Publication history
- Received October 21, 2017
- Accepted November 13, 2017
- First published December 8, 2017.
Online issue publication
April 12, 2018
Article Versions
- Previous version (8 December 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.